Cargando…

Pulmonary Hypertension: Unveiling Molecular Mechanisms, Diagnosis, and Therapeutic Targets

Detalles Bibliográficos
Autores principales:	Gredic, Marija, Hadzic, Stefan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10608029/ https://www.ncbi.nlm.nih.gov/pubmed/37888057 http://dx.doi.org/10.3390/jpm13101446

Ejemplares similares

New Therapeutic Target for Pulmonary Arterial Hypertension
por: Yoon, Kyung Lim
Publicado: (2018)

Cardiopulmonary Pathogenic Networks: Unveiling the Gut–Lung Microbiome Axis in Pulmonary Arterial Hypertension
por: Oliveira, Suellen Darc
Publicado: (2022)

Pulmonary Hypertension: Diagnosis and Management
por: Torbicki, Adam
Publicado: (2021)

Myeloid-cell-specific deletion of inducible nitric oxide synthase protects against smoke-induced pulmonary hypertension in mice
por: Gredic, Marija, et al.
Publicado: (2022)

Importance of differential diagnosis of pulmonary hypertension
por: Ogawa, Aiko
Publicado: (2013)

Pituitary Tumors: New Insights into Molecular Features, Diagnosis and Therapeutic Targeting
por: Fedele, Monica
Publicado: (2021)

Unveiling resistance mechanisms to EGFR inhibitors in cholangiocarcinoma
por: Vaquero, Javier, et al.
Publicado: (2018)

Udenafil as a Therapeutic Option for Pulmonary Arterial Hypertension
por: Kim, Hyung Yoon, et al.
Publicado: (2019)

Insights and Advances in the Diagnosis, Treatment, and Management of Pulmonary Hypertension
por: Guha, Ashrith, et al.
Publicado: (2021)

Ultrasonographic Prenatal Diagnosis: Unveiling the Path to Improved Antenatal Care
por: Granese, Roberta, et al.
Publicado: (2023)

Fibroblast growth factor 10 reverses cigarette smoke- and elastase-induced emphysema and pulmonary hypertension in mice
por: Hadzic, Stefan, et al.
Publicado: (2023)

Early Diagnosis in Pulmonary Arterial Hypertension: The Search for the Holy Grail
por: Berger, Rolf M. F., et al.
Publicado: (2019)

Combined Pulmonary Fibrosis and Emphysema: When Scylla and Charybdis Ally
por: Gredic, Marija, et al.
Publicado: (2023)

Unveiling the challenges of diabetic foot infections: diagnosis, pathogenesis, treatment, and rehabilitation
por: Park, Chul Hyun
Publicado: (2023)

Molecular Imaging in Targeted Therapeutics
por: Wang, Yuebing, et al.
Publicado: (2018)

DNA methyltransferase 3B deficiency unveils a new pathological mechanism of pulmonary hypertension
por: Yan, Yi, et al.
Publicado: (2020)

An Emotional Molecular Pathway in Pulmonary Hypertension–Alternative Complement System
por: Grunig, Gabriele, et al.
Publicado: (2020)

Targeting epigenetic mechanisms as an emerging therapeutic strategy in pulmonary hypertension disease
por: Bisserier, Malik, et al.
Publicado: (2019)

Phenotyping pulmonary hypertension in systemic sclerosis: a moving target
por: Mercurio, Valentina, et al.
Publicado: (2018)

Targeting ATP-Sensitive K(+) Channels to Treat Pulmonary Hypertension
por: Breen, Ellen, et al.
Publicado: (2022)

Pulmonary Hypertension
por: Basyigit, Ilknur, et al.
Publicado: (2012)

Hypertension and Cardiovascular Diseases: From Etiopathogenesis to Potential Therapeutic Targets
por: Bernatova, Iveta, et al.
Publicado: (2022)

Clarifying the Pulmonary Arterial Hypertension Molecular Landscape Using Functional Genetics
por: Maron, Bradley A.
Publicado: (2020)

Pulmonary Hypertension: Current Diagnosis, Approach and Treatment at the Dawn of the New European Guidelines
por: Orfanos, Stylianos E., et al.
Publicado: (2022)

Pathological Mechanisms and Potential Therapeutic Targets of Pulmonary Arterial Hypertension: A Review
por: Xiao, Ying, et al.
Publicado: (2020)

Emerging Pathogenetic Mechanisms of Pulmonary Arterial Hypertension: Nitric Oxide and More
por: Kim, Young Dae
Publicado: (2011)

Is VEGF a new therapeutic target for hypertension in chronic kidney disease?
por: Kim, Yon Su
Publicado: (2013)

Molecular markers as therapeutic targets in lung cancer
por: Tseng, Hsin-Hui, et al.
Publicado: (2013)

Beyond mechanical loading: The metabolic contribution of obesity in osteoarthritis unveils novel therapeutic targets
por: Sobieh, Basma H., et al.
Publicado: (2023)

Primary Pulmonary Hypertension
por: Haworth, Sheila G
Publicado: (1998)

Molecular Characterization and Elucidation of Pathways to Identify Novel Therapeutic Targets in Pulmonary Arterial Hypertension
por: Yao, Xiaoting, et al.
Publicado: (2021)

Molecular Mechanisms, Diagnosis and Treatments in Digestive Malignancy
por: Kanda, Tatsuo, et al.
Publicado: (2023)

The Cellular Landscape of Chronic Thromboembolic Pulmonary Hypertension Revealed by Single-Cell Sequencing: Therapeutic Implications?
por: Quarck, Rozenn, et al.
Publicado: (2023)

Unveiling the druggable RNA targets and small molecule therapeutics
por: Sztuba-Solinska, Joanna, et al.
Publicado: (2019)

Screening for pulmonary hypertension secondary to pulmonary tuberculosis
por: Raine, Richard
Publicado: (2020)

Non-coding RNAs and Hypertension–Unveiling Unexpected Mechanisms of Hypertension by the Dark Matter of the Genome
por: Murakami, Kazuo
Publicado: (2015)

Epigenetic Mechanisms as Emerging Therapeutic Targets and Microfluidic Chips Application in Pulmonary Arterial Hypertension
por: Ho, Linh, et al.
Publicado: (2022)

Study of the Molecular Mechanisms of the Therapeutic Properties of Extracellular Vesicles
por: Silachev, Denis N.
Publicado: (2023)

Demyelinating Diseases: From Molecular Mechanisms to Therapeutic Strategies
por: Bernardo, Antonietta, et al.
Publicado: (2023)

Diabetic Nephropathy: Novel Molecular Mechanisms and Therapeutic Avenues
por: Oltean, Sebastian, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_a1n4hlgtpklrsoburf86llq3jn